Adelaide is the Ideal Life Sciences Location

Jul 22, 2016

Creating an attractive city for health and life sciences companies happens through executing a well-designed strategy backed by a clear vision. Global companies are now discovering Adelaide, a city which is being transformed into the ideal location for clinical trials, research and development, medtech manufacturing, and distributing in Asia. Marco Baccanti, Chief Executive at Health Industries South Australia, reflects on a specific area – Adelaide – and explains why this city is ideal for life sciences. ...

Read More

The Great Brain Drain

Jul 22, 2016

The life sciences industry is drowning beneath a sea of new regulations and directives. As well as being immensely demanding from a risk management perspective, the associated administration is detracting from core activities. Even basic administrative tasks, such as checking updates to labelling, consume hours of PhDqualified staff time – capacity firms cannot afford. This is having an effect on professionals’ morale. Organisations should take heed, or risk losing valued experts at a time when experienced regulatory and QA personnel are in short supply, warns Dr Jutta Hohenhörst of Schlafender Hase. ...

Read More

Incorporating the Patient Perspective: The Critical Role of Human Factors and Usability in Improving Medication Adherence

Jul 22, 2016

Although we may not always notice it, the products we use in our daily lives continually evolve as manufacturers keep a close eye on consumer behaviour. Typically, they’re constantly adjusting and improving those goods based on feedback from surveys, focus groups and, of course, online commentary and criticism. Chris Evans, Vice President, Global Innovation at West Pharmaceutical Services, highlights the critical role of human factors from the patient’s perspective. ...

Read More

The NHS Must Invest in Order to Drive Efficencies

Jul 22, 2016

The NHS needs to embrace technology for the management of medication and supplies throughout hospitals if it wants to realise the cost savings detailed in the recent Lord Carter report, and meet GS1 standards. Lord Carter’s report highlighted that in 2012/13, expenditure on hospital medicines showed a staggering 11% increase on the previous year, to £6.5 bn. Lord Carter believes that there are greater savings to be had by managing the demand for medicines via better inventory management systems. He went on to state that all trusts should have key digital information systems in place, fully integrated and utilised by ...

Read More